482 results on '"Tur-Kaspa R"'
Search Results
2. Teaching the Interplay Between Social Determinants of Health (SDH) and Health Outcomes: the ETGAR Student-Delivered Service
3. The longitudinal kinetics of antibodies in COVID-19 recovered patients over 14 months
4. Immunohistochemical evaluation of hepatic oval cell activation and differentiation toward pancreatic beta-cell phenotype in streptozotocin-induced diabetic mice
5. Role of circulating soluble CD40 as an apoptotic marker in liver disease
6. Suppression of hepatitis C virus by the flavonoid quercetin is mediated by inhibition of NS3 protease activity
7. Nitric Oxide Metabolites in Decompensated Liver Cirrhosis
8. SARS-CoV-2 specific memory B cells frequency in recovered patient remains stable while antibodies decay over time
9. SARS-CoV-2 serological testing using electrochemiluminescence reveals a rapid onset of seroconversion in severe COVID-19 patients
10. Magnetic resonance cholangiopancreatography for the accurate diagnosis of biliary complications after liver transplantation: comparison with endoscopic retrograde cholangiography and percutaneous transhepatic cholangiography – long-term follow-up
11. Prevention of recurrent hepatitis B virus infection after liver transplantation: hepatitis B immunoglobulin, antiviral drugs, or both? Systematic review and meta-analysis
12. Low weight predicts neutropenia and peginterferon alfa-2a dose reductions during treatment for chronic hepatitis C
13. Lamivudine prevents reactivation of hepatitis B and reduces mortality in immunosuppressed patients: systematic review and meta-analysis
14. DisseminatedNocardia transvalensis infection resembling pulmonary infarction in a liver transplant recipient
15. Predictive value of serum globulin levels for the extent of hepatic fibrosis in patients with chronic hepatitis B infection
16. Lamivudine treatment for acute severe hepatitis B: a pilot study
17. Circulating soluble cytochrome c in liver disease as a marker of apoptosis
18. Experience with lamivudine therapy for hepatitis B virus infection before and after liver transplantation, and review of the literature
19. Acute Liver Failure Complicating Ductal Breast Carcinoma: Two Cases and Literature Review
20. Cell transformation induced by hepatitis C virus NS3 serine protease
21. Combination hepatitis B immune globulin and lamivudine versus hepatitis B immune globulin monotherapy in preventing recurrent hepatitis B virus infection in liver transplant recipients
22. BASAL AND POSTMETHIONINE LOAD PLASMA HOMOCYSTEINE LEVELS IN PATIENTS WITH CHRONIC LIVER DISEASE
23. LONG TERM BENEFICIAL EFFECT OF ALPHA INTERFERON IN PATIENTS BEARING HEPATITIS B PRECORE MUTANT
24. CLINICAL SIGNIFICANCE OF COINFECTION WITH HEPATITIS G (GBV-C) AND TT VIRUSES IN MULTITRANSFUSED PATIENTS
25. MUTATIONS AT THE VICINITY OF THE CATALYTIC SITES OF HEPATITIS C NS3 SERINE PROTEASE GENE ISOLATED FROM HEPATOCELLULAR CARCINOMA TISSUE
26. AMANTADINE AND INTERFERON TREATMENT OF CHRONIC HEPATITIS C PATIENTS - PRELIMINARY ANALYSIS
27. EFFICACY OF LAMIVUDINE IN PATIENTS WITH HEPATITIS B VIRUS PRE-CORE MUTANT INFECTION PRE- AND POST- LIVER TRANSPLANTATION
28. C13/06 BENEFICIAL EFFECT OF LAMIVUDINE PRE- AND POST-LIVER TRANSPLANTATION FOR HEPATITIS B INFECTION
29. Beta-2 microglobulin and serum creatinine for differentiating between immunoactivation and renal failure after liver transplantation
30. Combination of interferon-α and ribavirin therapy for recurrent hepatitis C virus infection after liver transplantation
31. Switching immunoglobulin base therapy to nucleoside/nucleotide analogues monotherapy is safe and effective as preventive therapy of reccurent HBV in liver transplanted patients- single centre experience
32. Resistance of Hepatitis Delta Virus Replication to Interferon-α Treatment in Transfected Human Cells
33. Occurrence and recurrence of malignancies post DAA Treatment in 5.1% of patients- single center experience
34. An Interim Analysis of a National Program for Treating Hepatitis C with Novel Antiviral Agents
35. Transcriptomic Antagonism between HCV Infection and Vitamin D
36. FRI-309 - Switching immunoglobulin base therapy to nucleoside/nucleotide analogues monotherapy is safe and effective as preventive therapy of reccurent HBV in liver transplanted patients- single centre experience
37. Association of post-liver transplantation diabetes mellitus with hepatitis C virus infection
38. De novo tumors after liver transplantation: a single-center experience
39. Cholestasis and hypoalbuminemia as predictors of outcome after liver transplantation
40. Comparison of tacrolimus with cyclosporin as primary immunosuppression in patients with hepatitis C virus infection after liver transplantation
41. Transfusion-transmitted virus in liver-transplanted children
42. Experience with 100 liver transplant recipients at the Rabin Medical Center and Schneider Children’s Medical Center
43. Cytokine gene polymorphism in liver allograft recipients
44. Passive immunization with OMRI-hep-B for prevention of hepatitis B virus reinfection after liver transplantation
45. Transmission of hepatitis B and C viruses--update
46. Conversion of liver allograft recipients from cyclosporine A to FK 506 immunosuppressive therapy
47. FRI-418 - An Interim Analysis of a National Program for Treating Hepatitis C with Novel Antiviral Agents
48. THU-267 - Transcriptomic Antagonism between HCV Infection and Vitamin D
49. SLE patient with respiratory symptoms — An unusual cause
50. Suppression of hepatitis C virus by the flavonoid quercetin is mediated by inhibition of NS3 protease activity
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.